Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD ...
NorUDCA de Shilpa Medicare entre dans l'histoire en tant que ...
Norgine completes acquisition of Theravia. Norgine Austria Belgium ...
AVAIO Digital Achieves Major Development Milestone at the Fully ...
TOPDON Releases Professional Grade V3000 Jump Starter with 3000A ...
Ankura Launches Turnaround & Restructuring Practice in Germany ...
Norgine finalise l'acquisition de Theravia. Norgine Austria Belgium ...
Norgine schließt Übernahme von Theravia ab. Norgine Austria ...
Transaction in Own Shares. Molten Ventures Plc / GB00BY7QYJ50 ...
JOST increases sales and earnings supported by the integration ...
Haier Smart Home Co. Ltd.: Preliminary announcement of the publication ...
GLOBAL FASHION GROUP REPORTS Q2 2025 RESULTS
MBB SE increases EBITDA by 37% in first half-year and confirms ...
Aquis Stock Exchange: Application for Admission Announcement
Half-year results: PNE AG reports operational success in H1
Suntory Expands Partnership with Rimini Street to Build an Innovative ...
MLP SE: H1 2025: New record set for revenue, EBIT forecast for full year confirmed ...
Aumann reports solid operating results for the first half of ...
Navamedic ASA: Financial report for the 2nd quarter and first ...
Medulla Expands Global Footprint with Strategic Launch in Singapore ...
adesso SE increases sales by 12% to EUR 709.5 million in the ...
HHLA closes first half of 2025 very successfully
JDC Group AG defies Liberation Day environment: Revenue grows ...
Hapag-Lloyd: good growth and solid half-year results in a volatile ...
DOUGLAS Group achieves solid growth and confirms guidance for ...
Hexagon Composites ASA: Second quarter 2025
Bioretec Ltd's Half-year report 2025: Strong support for future ...
Deutsche Konsum REIT-AG publishes its third quarter report for ...
BRI Launches Taipei Branch to Provide Financial Services for ...
Swiss Re reports a net income of USD 2.6 billion for the first ...
3U HOLDING AG: sound development of business in the first half ...
CEWE confirms annual forecast with strong Q2 turnover
Relief Therapeutics Publishes 2025 Half-Year Report